OCA
ETNB

Octagon Capital Advisors’s 89bio ETNB Stock Holding History

Octagon Capital Advisors’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,219,157
Closed -$18.8M – 37
2023
Q3 		$18.8M Buy
1,219,157
+152,373
+14% +$2.56M 2.89% 12
2023
Q2 		$20.2M Buy
1,066,784
+666,784
+167% +$11.7M 2.81% 10
2023
Q1 		$6.09M Buy
400,000
+20,000
+5% +$261K 0.88% 22
2022
Q4 		$4.84M Buy
+380,000
New +$3.42M 0.75% 23

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Octagon Capital Advisors's ETNB Position: Q4 2023 in Review

Octagon Capital Advisors sold out of 89bio (ETNB) in Q4 2023, closing a stake of 1,219,157 shares — an estimated $18.8M sold.

Octagon Capital Advisors first reported a position in ETNB in Q4 2022 and held it in 4 quarters. The position peaked at $20.2M in Q2 2023. 153 funds tracked by Wall St. Rank hold ETNB as of Q4 2023.

  • Octagon Capital Advisors reported no remaining 89bio position as of Q4 2023 after selling out during the quarter.
  • Octagon Capital Advisors sold 1,219,157 89bio shares in Q4 2023, an estimated $18.8M.
  • Octagon Capital Advisors first reported a position in 89bio in Q4 2022 and held it in 4 quarters.
  • Octagon Capital Advisors's 89bio position peaked at $20.2M in Q2 2023.
  • 153 funds tracked by Wall St. Rank held 89bio as of Q4 2023.

Based on Octagon Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.